Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

AbstractBackground Chimeric antigen receptor (CAR) T-cell therapy shows impressive results in clinical trials. We conducted a meta-analysis based on the most recent data to systematically describe the efficacy and safety of anti-BCMA CAR T therapy for patients with relapsed or refractory multiple my...

Full description

Bibliographic Details
Main Authors: Lina Zhang, Xuxing Shen, Wenjun Yu, Jing Li, Jue Zhang, Run Zhang, Jianyong Li, Lijuan Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Annals of Medicine
Subjects:
Chimeric antigen receptor T-cell therapy
multiple myeloma
efficacy
safety
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2021.1970218

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2021.1970218

Similar Items